UNIVERSE PHARMACEUTICALS INC

Historical 13F Holders

Symbol
UPC
CUSIP
G9442G104
All holders as of
Q2 2023
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G9442G104 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Sabby Management, LLC 13G
Amended under CUSIP G9442G138 on 1/7/2026
9.9% 1/3/2025
Event 12/31/2024
Anson Funds Management LP 13G/A
1.0% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 5 98.5 k $33.7 k
2023 Q1 3 71.5 k $40.0 k
2022 Q4 4 65.7 k $93.7 k
2022 Q3 4 44.2 k $24.0 k
2022 Q2 5 290 k $181 k
2022 Q1 5 1.11 M $1.40 M
2021 Q4 6 1.19 M $1.95 M
2021 Q3 6 341 k $844 k
2021 Q2 4 40.9 k $151 k
2021 Q1 5 82.9 k $332 k